HIV Slides 1-13: Intro Flashcards

1
Q

How do retroviruses work?

A

Reverse transcriptase integrates viral RNA into host DNA - stays forever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do viral oncogenes do?

A

Transform the host cell to express oncogenes, growth factors. Malignant transformation occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What do host proto-oncogenes do?

A

Host non active genes that viral DNA activates to transform cells.
Leukemia or sarcoma viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is HTLV1

A

Human T-cell leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is HTLV2?

A

Hairy T-cell leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the origin of HIV?

A

Cross-species transmission of Simian Immunodeficiency virus (SIV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does HIV infect the cells?

A

Binds CD4 receptor on human t-lymphocytes (gp 120 and gp 41 on virus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What proteins does the HIV virus code for?

A

Reverse transcriptase, integrase, and protease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do viral encoded proteases do?

A

Cleave functional viral proteins from precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many new virions are produced each day?

A

10^9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Infected T-cells have a half life of?

A

1.6 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Time from release of new virion to infection of a new cell and release of another new virion is?

A

2.6 days

140 generations of virus each year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the goals of therapy for HIV?

A

Maximal and durable suppression of viral load (HIV RNA less than 50 copies per mL)

Reduction of HIV-related morbidity and mortality

Improvement of quality of life

Restoration of immunologic function

Prevent HIV transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What treatment considerations are there for HIV?

A

Resistance (6-16% to at least one drug class)
Tropism (CCR5 or CXCR4)
Contraindications (CD4 count/HLA typing)
Co-morbidities (Hepatitis)
Adherence potential (greater than 95%) - dosing frequency, number, size of pills, cost, food and fluid restrictions
Adverse drug reactions (Potential drug interactions and pregnancy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In the first 2-4 weeks, what occurs to CD4+ cell count?

A

It decreases, then increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In the first 6-10 years, what happens to CD4+ cell count?

A

It continues to decrease

17
Q

In the last 2-3 years of HIV, what happens to CD4+ cell counts?

A

It continues to decrease

18
Q

In the first 2-4 weeks, what happens to virus levels in the blood?

A

They increase to a peak, causing flu like symptoms

19
Q

In the first 6-10 years, what happens to virus levels in the blood?

A

They decrease but stay at steady levels

20
Q

In the last 2-3 years, what happens to virus levels in the blood?

A

They start to increase again,

21
Q

What happens to anti-HIV antibody in the first 2-4 weeks?

A

They begin to increase when the HIV virus levels spike

22
Q

What happens to anti-HIV antibody in the first 6-10 years?

A

They increase to a peak and stay steady

23
Q

What happens to anti-HIV antibody in the last 2-3 years?

A

They start to decrease as virus levels increase

First skin and mucous membrane immune defects occur, then systemic immune deficiency

24
Q

When do we treat HIV patients?

A

All HIV infected individuals should be treated regardless of CD4 count to reduce morbidity and mortality from HIV infections and prevent transmission by infected individuals.

25
Q

What groups of patients require special attention with HIV treatment/

A

Pregnant women
Patients with HIV associated nephropathy, HIV associated dementia, or malignancies
Patients co-infected with HBV or HBC when treatment is indicated

26
Q

All patients treated for HIV should receive what?

A

Genotypic drug resistance
HLA-B 5701 testing (hypersensitivity reaction with Abacavir)
Co-receptor tropism testing (prior to Maraviroc use; CCR5 changes to CXCR4 or mixed tropic with decreased CD 4 counts)
Plasma viral RNA load (at baseline and regular basis thereafter esp after changes in therapy)

27
Q

What are the general treatment guidelines for HIV?

A

Two nucleoside reverse transcriptase inhibitors plus ONE of the following groups:

Non nucleoside reverse transcriptase inhibitor (2 NRTI + 1 NNRTI)

Protease inhibitor (boosted with Ritonavir) (2 NRTI + 1-2 PI)

Integrase stand transfer inhibitor based (2 NRTI + INSTI)